MedTrace Logo

Feasibility Testing and Pilot Study of V-MOTIVE Protocol Software Version 1

NCT02500771 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2015-07-17

No results posted yet for this study

Summary

This is a project to be funded by a Fast-Track Small Business Innovative Research to build and test the feasibility of a new software prototype called V-Motive which will facilitate the combination of two proven autism behavioral interventions: Applied Behavior Analysis therapy (ABA) and Video Modeling (VM). The investigators will conduct a Phase I feasibility analysis and Phase II pilot study of the V-Motive Prototype by observing a community therapy providers' use of the prototype in a therapy setting. Investigators will observe the users and record the success or failure of the performance of key functions of the software. Investigators will also administer surveys. The study will answer research questions about V-Motive's ability to perform its intended function: allowing interventionists to feasibly leverage video modeling within ABA therapy with a minimal amount of overhead and labor.

Conditions

Interventions

BEHAVIORAL

ABA therapy enhanced with V-Motive software

Tutors will use the V-Motive software to enhance their delivery of Applied Behavioral Analysis therapy.

Sponsors & Collaborators

  • northwest behavioral associates

    collaborator UNKNOWN

  • Experiad LLC

    lead INDUSTRY

Principal Investigators

  • Rex Jakobovits · Experiad LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500771 on ClinicalTrials.gov